化合物PF-05221304 基本信息
| 中文名称 | 化合物PF-05221304 |
|---|---|
| 中文同义词 | 化合物PF-05221304;4-(4-(1-异丙基-7-氧代-1,4,6,7-四氢螺[吲唑-5,4'-哌啶]-1'-羰基)-6-甲氧基吡啶-2-基)苯甲酸;4-(4-(1-ISOPROPYL-7-OXO-1,4,6,7-TETRAHYDROSPIRO[INDAZOLE-5,4'-PIPERIDIN]-1'-YLCARBONYL)-6-METHOXYPYRIDIN-2-YL)BENZOIC ACID;4-(4-(1-异丙基-7-氧代-1,4,6,7-四氢螺[吲唑-5,4'-哌啶]-1'-基羰基)-6-甲氧基吡啶-2-基)苯甲酸;4-(4-(1-异丙基-7-氧代-1,4,6,7-四氢螺[吲唑-5,4'-哌啶]-1'-羰基)-6-甲氧基吡啶-2-基)苯甲酸 |
| 英文名称 | 4-(4-(1-isopropyl-7-oxo-1,4,6,7-tetrahydrospiro[indazole-5,4'-piperidine]-1'-carbonyl)-6-methoxypyridin-2-yl)benzoicacid |
| 英文同义词 | 4-(4-(1-isopropyl-7-oxo-1,4,6,7-tetrahydrospiro[indazole-5,4'-piperidine]-1'-carbonyl)-6-methoxypyridin-2-yl)benzoicacid;EOS-62091;Benzoic acid, 4-[6-methoxy-4-[[1,4,6,7-tetrahydro-1-(1-methylethyl)-7-oxospiro[5H-indazole-5,4'-piperidin]-1'-yl]carbonyl]-2-pyridinyl]-;PF-05221304(Clesacostat);STAT5 Inhibitor III;PF-05221304;Clesacostat;PF 05221304,PF05221304 |
| CAS号 | 1370448-25-1 |
| 分子式 | C28H30N4O5 |
| 分子量 | 502.56 |
| EINECS号 | |
| 相关类别 | |
| Mol文件 | 1370448-25-1.mol |
| 结构式 |  |
化合物PF-05221304 性质
| 沸点 | 745.3±60.0 °C(Predicted) |
|---|---|
| 密度 | 1.36±0.1 g/cm3(Predicted) |
| 储存条件 | Store at -20°C |
| 溶解度 | DMSO：100 mg/mL (198.98 mM)；乙醇：5 mg/mL (9.95 mM) |
| 酸度系数(pKa) | 3.93±0.10(Predicted) |
| 水溶解性 | Water: Insoluble |